Medifast (MED) Tops Q2 EPS by 133c, beats revenue, provides outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| MEDIFAST, Inc. (NYSE: MED) | Delayed: 12.17 +0.07 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.10 | 52 Week High | $42.14 | |||
| Open | $12.00 | 52 Week Low | $27.12 | |||
| Day High | $12.23 | P/E | 8.22 | |||
| Day Low | $12.00 | EPS | $1.48 | |||
| Volume | 24,866 | |||||
